Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection represents a global health crisis. Immune cell activation via pattern recognition receptors has been implicated as a driver of the hyperinflammatory response seen in COVID-19. However, our understanding of the specific immune respons...
Main Authors: | Simon Gebremeskel, Julia Schanin, Krysta M. Coyle, Melina Butuci, Thuy Luu, Emily C. Brock, Alan Xu, Alan Wong, John Leung, Wouter Korver, Ryan D. Morin, Robert P. Schleimer, Bruce S. Bochner, Bradford A. Youngblood |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.650331/full |
Similar Items
-
Discovery, Function, and Therapeutic Targeting of Siglec-8
by: Bradford A. Youngblood, et al.
Published: (2020-12-01) -
Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
by: Piper A. Robida, et al.
Published: (2022-03-01) -
Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells
by: Yun Cao, et al.
Published: (2023-10-01) -
Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
by: Chang-Shin Park, et al.
Published: (2011-06-01) -
Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro
by: Daniela J. Carroll, et al.
Published: (2021-10-01)